Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response.
about
Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strainsExposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycleTCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposureAntibiotics trigger initiation of SCCmec transfer by inducing SOS responses.Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections.β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus.Antimicrobial heteroresistance: an emerging field in need of clarity.Role of the Stringent Stress Response in the Antibiotic Resistance Phenotype of Methicillin-Resistant Staphylococcus aureus.VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strains.Propyl-5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate (HMPC): a new bacteriostatic agent against methicillin-resistant Staphylococcus aureus.
P2860
Q28486717-C22FE58D-A299-4ED7-9DF8-8CD089ABDE05Q28535076-F75D77F4-16F7-4CD6-A9BE-E5080EBE0B52Q28539724-8130739E-43DA-4C73-AAF9-6C302CDC1FB1Q33580265-3E051F45-7EA0-4678-AC6F-D245EE9B6437Q34229656-0EC9F6F0-D549-42C2-99C4-656D1330906FQ36396117-D336EB7D-55E8-4718-BE79-3CDB8BA40BADQ38052949-F4B07824-D971-4CCF-9FE0-FC698F2AB49AQ38310639-372CC718-7311-4AB0-B972-97DEC5D198E2Q39514701-7C315CE7-B13D-4B42-A635-C4B9E01D5963Q40327375-28268B31-5CC9-4809-8151-B69A8F8BC8F6Q42206236-9C2E4F45-5C8B-4E17-9F72-A817F3A67EDFQ42697562-59FF242E-8FA3-4400-A37F-8C3E8A4DE17EQ53687606-42540CFE-ACEB-4354-AFAD-EAC482FC7AFA
P2860
Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a beta-lactam-mediated SOS response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of homogeneous exp ...... -lactam-mediated SOS response.
@en
Development of homogeneous exp ...... -lactam-mediated SOS response.
@nl
type
label
Development of homogeneous exp ...... -lactam-mediated SOS response.
@en
Development of homogeneous exp ...... -lactam-mediated SOS response.
@nl
prefLabel
Development of homogeneous exp ...... -lactam-mediated SOS response.
@en
Development of homogeneous exp ...... -lactam-mediated SOS response.
@nl
P2860
P356
P1476
Development of homogeneous exp ...... -lactam-mediated SOS response.
@en
P2093
Arabela Cuirolo
Konrad Plata
P2860
P356
10.1093/JAC/DKP164
P407
P577
2009-05-20T00:00:00Z